Pular para o conteúdo principal
Ranking Invest

ALDX - Aldeyra Therapeutics, Inc.

Segmento: HealthcareAldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma. The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Análise Ranking Invest

Valor de Mercado
$ 41.24 Mi
IVR
-2.65Índice proprietário de comparação relativa: -2,65.
IVR2
-3.57Leitura proprietária complementar: -357%.
MLL
-3.57Leitura proprietária complementar: -357%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 37.89 Mi

L4T

-$ 23.05 Mi

Indicadores Básicos

ROE

-60.85%

Índices de Previsibilidade

Receita Líquida

G1.82

Lucro

C0.29

Margem

E1.69

Índices de Tendência

Receita Líquida

D0.79

Lucro

B5.93

Margem

C1.58

Índices de Endividamento

DIV/PAT

0.00

DIV/L4T

0.00

Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.